Grasmeijer, Floris
60  results:
Search for persons X
?
1

Pulmonary:

, In: Practical Pharmaceutics,
 
?
 
?
4

Natural and bioinspired excipients for dry powder inhalatio..:

Zillen, Daan ; Beugeling, Max ; Hinrichs, Wouter L.J...
Current Opinion in Colloid & Interface Science.  56 (2021)  - p. 101497 , 2021
 
?
5

The pharmacokinetics of antibiotics in cystic fibrosis:

Akkerman-Nijland, Anne M. ; Akkerman, Onno W. ; Grasmeijer, Floris...
Expert Opinion on Drug Metabolism & Toxicology.  17 (2020)  1 - p. 53-68 , 2020
 
?
6

A comparative analysis of changes in pMDI drug dose deliver..:

Hagedoorn, Paul ; Bawary, Wasiq ; Frijlink, Henderik Willem.
The Journal of Allergy and Clinical Immunology: In Practice.  8 (2020)  3 - p. 1124-1125.e4 , 2020
 
?
9

Pharmacokinetics and tolerability of inhaled levodopa from ..:

Luinstra, Marianne ; Rutgers, Wijnand ; van Laar, Teus...
Therapeutic Advances in Chronic Disease.  10 (2019)  - p. 204062231985761 , 2019
 
?
11

Challenges for pulmonary delivery of high powder doses:

Sibum, Imco ; Hagedoorn, Paul ; de Boer, Anne Haaije..
International Journal of Pharmaceutics.  548 (2018)  1 - p. 325-336 , 2018
 
?
12

A levodopa dry powder inhaler for the treatment of Parkinso..:

Luinstra, Marianne ; Grasmeijer, Floris ; Hagedoorn, Paul...
European Journal of Pharmaceutics and Biopharmaceutics.  97 (2015)  - p. 22-29 , 2015
 
?
14

The dispersion behaviour of dry powder inhalation formulati..:

Grasmeijer, Floris ; de Boer, Anne H.
International Journal of Pharmaceutics.  465 (2014)  1-2 - p. 165-168 , 2014
 
?
15

A proposed definition of the 'activity' of surface sites on..:

Grasmeijer, Floris ; Frijlink, Henderik W. ; de Boer, Anne H.
European Journal of Pharmaceutical Sciences.  56 (2014)  - p. 102-104 , 2014
 
1-15